Skip to main content
. 2002 Feb;53(2):163–171. doi: 10.1046/j.0306-5251.2001.01531.x

Table 5.

Dyspeptic symptoms assessment.

H. pylori eradicated H. pylori persistent
Dyspeptic Follow-up pre and post treatment (n = 64) Follow-up pre and post treatment (n = 12)
symptoms Time* 0 1 6 0 1 6
Epigastric pain
 nil 4 61 63 2 2 2
 mild 1 3 1 0 0 0
 moderate 9 0 0 1 2 2
 severe 50 0 0 9 8 8
% with symptom 93.8% 4.7% 1.6% 83.3% 83.3% 83.3%
Heartburn
 nil 16 50 61 3 3 3
 mild 1 14 3 0 0 0
 moderate 7 0 0 1 2 0
 severe 40 0 0 8 7 9
% with symptom 75% 21.9% 3.2% 75% 75% 75%
Nausea
 nil 29 60 64 5 7 3
 mild 15 3 0 3 2 3
 moderate 10 1 0 3 2 2
 severe 10 0 0 2 1 4
% with symptom 55% 4.7%  0% 66.7% 41.7% 75%
Vomiting
 nil 33 63 64 6 12 6
 mild 22 1 0 5 0 5
 moderate 7 0 0 1 0 1
 severe 2 0 0 0 0 0
% with symptom 48.4% 1.6%  0% 50%  0% 50%
Wind
 nil 30 52 64 4 4 4
 mild 3 12 0 0 0 0
 moderate 9 0 0 3 2 2
 severe 22 0 0 5 6 6
% with symptom 46.8% 18.8%  0% 66.7% 66.7% 66.7%
*

0: symptoms severity before eradication therapy; 1, 6: symptoms severity 1 and 6 months after completion of eradication therapy.